[ad_1]
Dublin, February 20, 2023 /PRNewswire/—— “UAE Insulin Market by Indication (Type I Diabetes, Type II Diabetes), Route of Administration (Subcutaneous, Intranasal, Intravenous, Transdermal, Oral, etc.), Type, Time of Onset, Product, Region, Competitive Forecast and Opportunity , 2027” report added to ResearchAndMarkets.com’s supply.
The UAE human insulin market is expected to grow at an impressive CAGR over the forecast period 2023 to 2027, owing to rising cases of diabetes among the country’s population. Continuous advancements in the pharmaceutical industry and surge in demand for pharmaceutical products to manage high blood sugar levels in the population are further driving the growth of the UAE human insulin market over the next five years.
Moreover, increasingly sedentary lifestyles among adults and youth leading to lifestyle diseases such as obesity, blood pressure and blood sugar disturbances are also contributing to the growth of the UAE insulin market over the next five years.
Synthetic insulin designed and manufactured in a laboratory is called human insulin. In the laboratory, human insulin is produced by growing the insulin protein in Escherichia coli (E-Coli) bacteria and then extracting the insulin from the bacteria.
Bacterial cultures are grown in a controlled environment that maintains the hygiene and purity of the bacterial culture. Before the discovery of human insulin, animal insulin was used in a purified form for pigs (pigs/pigs). There are two main forms of human insulin regular insulin and neutral protamine Hegedorn insulin.
Diabetes Instances Driving Market Growth
Rising cases of diabetes among the country’s population is the most important factor driving the growth of the UAE insulin market over the next five years. By 2021, more than 990 people in every 1,000 people in the country will suffer from diabetes. Diabetes cases are higher in the country’s older population.
In this country, 1 in 5 people over the age of 69 has diabetes. In 2019, more than 19 percent of the adult population aged 20 to 79 had type 2 diabetes. The country is the 10th most diabetic country in the world.
Experts have even mentioned diabetes as a silent epidemic in the country as it is responsible for a much higher number of deaths compared to COVID-19. People with diabetes are strictly advised to monitor their health before and after vaccination as their immune system is severely affected. Therefore, the risk of COVID-19 infection increases exponentially.
Pharmaceutical advancements in insulin drug delivery poised for growth
Research and product development is ongoing in the country. The government is helping research institutes and pharmaceutical designers to improve drugs and drug delivery systems in order to derive highly efficient insulin delivery systems, which will further boost the growth of the UAE human insulin market over the next five years.
Trabolsi’s research group at NYU Abu Dhabi has developed a revolutionary technology in the oral insulin delivery system, which allows insulin to be administered orally without the side effects of frequent subcutaneous injections of insulin. The researchers developed gastric-resistant imide-linked covalent organic framework nanoparticles (nCOF) by using prepared nanosheet layers and loading insulin between the layers. The system is biocompatible, highly stable in the stomach, specific, and capable of delivering adequate amounts of insulin. Thus, future scope is provided for further development and consequently enhanced market growth.
market segmentation
In this report, the UAE Human Insulin Market is segmented into the following categories, furthermore, the following industry trends are detailed:
UAE Human Insulin Market, By Indication:
- Type I diabetes
- Type II diabetes
UAE Human Insulin Market, By Route of Administration:
- Subcutaneous
- nasal
- vein
- Percutaneous
- oral
- others
UAE Human Insulin Market, By Type:
- Base
- pill
- premixed
- biosimilars
- traditional
UAE Human Insulin Market, By Onset Time:
- Fast acting
- short-acting
- Intermediate acting
- Long-lasting
- super long-acting
- Premix
- inhale
UAE Human Insulin Market, By-Products:
- insulin pen
- Insulin Pump
- Infusion system
- injection
UAE Human Insulin Market, By Region:
- Abu Dhabi
- dubai
- Sharjah
- Rest of UAE
Key topics covered:
1. Product overview
2. Research methodology
3. Impact of COVID-19 on UAE Human Insulin Market
4. Voice of the Customer
5. Executive summary
6. UAE insulin market outlook
7. Prospects of Dubai Human Insulin Market
8. Sharjah Human Insulin Market Outlook
9. Abu Dhabi Human Insulin Market Outlook
10. Market Dynamics
11. Market trends and developments
12. Policy and Regulatory Environment
13. Overview of the UAE economy
14. Competitive landscape
15. Strategic Recommendations
Some of the companies mentioned in this report include
- Novo Nordisk Pharmaceuticals Gulf FZ-LLC
- Sanofi UAE
- Baxter International UAE
- B. Braun Medical Gulf FZ – LLC
- Lilly UAE
- Becton Dickinson And Company United Arab Emirates
- Gulf Pharmaceutical Industries PSC (Julphar)
For more information on this report, please visit https://www.researchandmarkets.com/r/j1pd1e-human-insulin?w=5
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source of international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and latest trends.
Media Contact:
Research and Market
laura woodSenior Manager
[email protected]
Eastern Office Hours please call +1-917-300-0470
US/Canada Toll Free +1-800-526-8630
Call +353-1-416-8900 during GMT office hours
US Fax: 646-607-1907
Fax (outside the US): +353-1-481-1716
ID: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Sources Research and Markets
[ad_2]
Source link